• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Lupin Limited — Updates, 05-12-2025: Press Release

    05-12-2025 | 09:25 am

    Lupin received tentative U.S. FDA approval for its Siponimod Tablets (MS treatment), to be manufactured in Pithampur. The reference drug (Mayzent®) had estimated annual U.S. sales of USD 19.5 Cr, highlighting a key market entry for Lupin.

    No comments yet. Be the first to comment!

    All announcements from Lupin Limited